Analytical Data
-
基因名
ZNFN1A3
- Application
-
别名
Zinc finger protein Aiolos. Ikaros family zinc finger protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UKT9
-
表达区间
1-509 aa
-
氨基酸序列
MEDIQTNAELKSTQEQSVPAESAAVLNDYSLTKSHEMENVDSGEGPANEDEDIGDDSMKVKDEYSERDENVLKSEPMGNAEEPEIPYSYSREYNEYENIKLERHVVSFDSSRPTSGKMNCDVCGLSCISFNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHTGEKPFKCHLCNYACQRRDALTGHLRTHSVEKPYKCEFCGRSYKQRSSLEEHKERCRTFLQSTDPGDTASAEARHIKAEMGSERALVLDRLASNVAKRKSSMPQKFIGEKRHCFDVNYNSSYMYEKESELIQTRMMDQAINNAISYLGAEALRPLVQTPPAPTSEMVPVISSMYPIALTRAEMSNGAPQELEKKSIHLPEKSVPSERGLSPNNSGHDSTDTDSNHEERQNHIYQQNHMVLSRARNGMPLLKEVPRSYELLKPPPICPRDSVKVINKEGEVMDVYRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGYRSHDRYEFSSHIARGEHRALLK
-
分子量
81.73 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNFN1A3, also known as Zinc Finger Protein 1A3, is a member of the zinc finger protein family, characterized by their ability to bind DNA and regulate gene expression. Research on ZNFN1A3 has gained traction due to its potential roles in various biological processes, including transcriptional regulation, cell differentiation, and development. Dysregulation of zinc finger proteins, including ZNFN1A3, has been implicated in several diseases, such as cancer and genetic disorders, making it a significant target for therapeutic intervention. The interest in recombinant ZNFN1A3 arises from the potential to produce this protein in a controlled manner for functional studies, structural analysis, and potential applications in gene therapy or synthetic biology. By utilizing recombinant DNA technology, researchers aim to elucidate the functional mechanisms of ZNFN1A3, understand its interactions with other cellular components, and explore its role in disease pathology. Overall, the study of recombinant ZNFN1A3 promises to provide insights into the intricate regulatory networks of gene expression and contribute to the development of innovative strategies for disease treatment.












